Encompass Health Corporation
EHC
$121.54
$0.250.21%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 151.50M | 120.90M | 108.20M | 114.10M | 112.50M |
| Total Depreciation and Amortization | 79.20M | 78.00M | 78.40M | 72.90M | 70.30M |
| Total Amortization of Deferred Charges | -- | 9.70M | -- | -- | -- |
| Total Other Non-Cash Items | 65.40M | 67.40M | 48.70M | 42.20M | 57.60M |
| Change in Net Operating Assets | -7.50M | 2.80M | 32.50M | -11.80M | -1.60M |
| Cash from Operations | 288.60M | 278.80M | 267.80M | 217.40M | 238.80M |
| Capital Expenditure | -163.10M | -198.70M | -147.50M | -156.90M | -139.40M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 4.60M | -5.00M | -14.00M | -1.50M | 9.70M |
| Cash from Investing | -158.50M | -203.70M | -161.50M | -158.40M | -129.70M |
| Total Debt Issued | 60.00M | 30.00M | 15.00M | 0.00 | 50.00M |
| Total Debt Repaid | -80.00M | -117.40M | -156.50M | -12.10M | -50.00M |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -51.90M | -7.50M | -6.80M | -16.80M | -12.10M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -18.00M | -17.00M | -15.00M | -14.90M | -15.90M |
| Other Financing Activities | -40.50M | -39.00M | 73.80M | -5.80M | -12.60M |
| Cash from Financing | -130.40M | -150.90M | -89.50M | -49.60M | -40.60M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -300.00K | -75.80M | 16.80M | 9.40M | 68.50M |